Black Cohosh (Actaea racemosa)

Table of Contents

1. Native American and European Use
2. Mechanism of Action
3. Menopausal Symptom Relief
4. Menstrual and Premenstrual Concerns
5. Polycystic Ovary Syndrome and Fertility
6. Forms and Preparations
7. Dosage
8. Cautions and Contraindications
9. Conditions It Is Used For
10. Featured Videos

Native American and European Use

Black cohosh is a tall woodland herb native to the eastern United States and Canada, with dark, knotted rhizomes that several Native American nations — including the Cherokee, Iroquois, and Algonquian-speaking peoples — used chiefly for women's reproductive complaints and for rheumatic pain. European settlers adopted it, it spent roughly a century in the U.S. Pharmacopoeia, and from 1956 it became, via German standardized extracts, one of the most-studied botanical medicines in the world for the menopausal transition — the fuller story is told in the dedicated History & Traditional Use article.

Back to Table of Contents

Mechanism of Action

Despite early speculation that black cohosh acts as a phytoestrogen, modern research has established that it does not bind significantly to estrogen receptors. Instead, its mechanism appears to involve serotonergic, dopaminergic, and GABAergic neurotransmitter pathways relevant to thermoregulation and mood, along with possible effects on the hypothalamic-pituitary axis.

Documented or proposed mechanisms include:

• Modulation of serotonin 5-HT7 receptors involved in central thermoregulation — a likely explanation for hot flash reduction
• Mild dopamine receptor activity contributing to mood effects
• Gamma-aminobutyric acid-receptor binding by certain triterpene glycosides, supporting sleep and anxiety reduction
• Anti-inflammatory and antioxidant activity from the cycloartane triterpenes and phenolic acids
• Lack of direct estrogenic activity makes it potentially safer than hormone replacement therapy for women with hormone-sensitive conditions

The major active compounds are triterpene glycosides — including actein, 23-epi-26-deoxyactein (formerly called 27-deoxyactein), cimiracemoside, and cimigenol — along with cinnamic acid esters and isoflavones. Standardized extracts — the most-studied is an isopropanolic (propan-2-ol) extract — are calibrated to triterpene glycoside content.

Back to Table of Contents

Menopausal Symptom Relief

Black cohosh's best-known use is for the vasomotor symptoms of menopause — hot flashes and night sweats. It has a long traditional use for menopausal complaints, and many women report fewer and milder hot flashes after several weeks of taking it. Multiple randomized controlled trials and meta-analyses have shown reductions in hot flash frequency and severity that, while smaller than hormone therapy, are clinically meaningful for many women. Typical findings include 25-50% reduction in hot flash frequency over 8-12 weeks of treatment. The European Medicines Agency's 2018 monograph lists standardized dry extracts, under “well-established use”, for the relief of menopausal complaints such as hot flushes and profuse sweating.

Beyond hot flashes, black cohosh has been shown in clinical studies to improve the symptoms below, and is traditionally used, and reported by women, for:

• Night sweats and sleep disturbance
• Menopausal mood changes including irritability and mild depression
• Anxiety associated with the menopausal transition
• Fatigue and energy
• Joint and muscle aches related to estrogen withdrawal
• Vaginal dryness (modest effect; topical estrogen remains more effective)

For women who cannot or prefer not to use hormone replacement therapy — including breast cancer survivors and women with personal or family history of estrogen-sensitive cancers — black cohosh is one of the most commonly used botanical options. Several trials have specifically evaluated its safety in breast cancer survivors and found no evidence of estrogenic stimulation.

Back to Table of Contents

Menstrual and Premenstrual Concerns

Although less extensively studied than its menopausal applications, black cohosh has a long traditional record for menstrual irregularity, dysmenorrhea (painful periods), and premenstrual mood symptoms. Modern clinical use for these indications is considered exploratory but reasonable based on its mechanism.

Particular utility may exist for women in late perimenopause with overlapping menstrual irregularity, hot flashes, and mood changes — a transitional phase where estrogen-receptor-binding herbs may be poorly tolerated.

Back to Table of Contents

Polycystic Ovary Syndrome and Fertility

Black cohosh is also used as an add-on to clomiphene citrate (a standard ovulation-induction medicine) in fertility treatment for women with polycystic ovary syndrome (PCOS), with the aim of a thicker womb lining (endometrium), a better hormone balance through the cycle and more pregnancies than with clomiphene alone. When added to clomiphene citrate, black cohosh has been associated with improved endometrial thickness, more favorable hormone profiles, and higher pregnancy rates compared with clomiphene alone in some studies.

The European Medicines Agency's 2018 monograph on black cohosh states that no fertility data are available and that safety in pregnancy has not been established; for lack of data, it lists use during pregnancy as not recommended.

Back to Table of Contents

Forms and Preparations

• Standardized extract (isopropanolic or ethanolic dry extract) — the most clinically studied form; tablets standardized to triterpene glycosides; the form used in nearly all major clinical trials
• Dried rhizome capsules — whole-rhizome powder; less precise dosing but traditional form
• Tinctures — 1:5 alcohol extracts; rapid absorption
• Combination formulas — frequently combined with St. John's wort (for menopausal mood), red clover (for hot flashes), or chasteberry (for cycle regulation)

Quality matters significantly with black cohosh: adulteration with the cheaper Asian species Actaea dahurica, Actaea cimicifuga, and Actaea heracleifolia is well documented in the supplement market. Some cases of liver toxicity historically attributed to black cohosh may actually have been due to species substitution. Species identity is verified in the laboratory by DNA fingerprinting or HPLC (high-performance liquid chromatography) fingerprinting.

Back to Table of Contents

Dosage

• Standardized dry extract — the European Medicines Agency's 2018 monograph gives daily doses of 5.6 mg (an ethanol 58% extract, 2.8 mg twice a day), 6.5 mg (an ethanol 60% extract, once a day) or 5.0 mg (a propan-2-ol 40% extract, 2.5 mg or 5.0 mg once or twice a day); the 16 trials in a 2012 Cochrane review used a median daily dose of 40 mg
• Dried rhizome powder — 40-200 mg daily of dried rhizome equivalent
• Tincture (1:5 in 60% alcohol) — 2-4 mL three times daily
• Onset — some women feel improvement within two to four weeks; full effect typically takes eight to twelve weeks
• Duration — traditionally limited to six months of continuous use (the EMA monograph also states that it is not taken for more than 6 months without medical advice); some practitioners use it longer with periodic liver blood tests (liver function tests)

Back to Table of Contents

Cautions and Contraindications

• Liver injury — the U.S. National Institutes of Health's LiverTox database states that products labelled as black cohosh have been implicated in many cases of acute liver injury, some of them severe and leading to emergency liver transplantation or death. The European Medicines Agency's 2018 monograph lists liver toxicity (hepatitis, jaundice, abnormal liver tests) as associated with black cohosh products, at an unknown frequency, and names the warning signs on which, it says, use is stopped and a doctor consulted immediately: tiredness, loss of appetite, yellowing of the skin and eyes, severe upper stomach pain with nausea and vomiting, or dark urine. Since 2008 the United States Pharmacopeia has called for a label statement to stop use for anyone with a liver disorder or symptoms of liver trouble, such as abdominal pain, dark urine or jaundice. Causation is debated: the Pharmacopeia's 2008 review rated all 30 liver case reports it examined as “possible” (none probable or certain), and some cases may have involved products containing other species. Some practitioners check liver blood tests (liver function tests) before and during long use.
• Pregnancy — the EMA monograph states that safety in pregnancy has not been established and, for lack of data, lists use in pregnancy as not recommended; black cohosh is also described as uterine-stimulating and has a historic use to induce labor
• Breastfeeding — the EMA monograph states that safety during breastfeeding has not been established and, for lack of data, lists use while breastfeeding as not recommended
• Hormone-sensitive cancers — although black cohosh does not appear to be estrogenic, the EMA monograph carries a warning for women who have been treated, or are being treated, for breast cancer or other hormone-dependent tumours: laboratory results have been contradictory, and the monograph states that an influence on these tumours cannot be excluded
• Liver disease — the EMA monograph states that people with a history of liver disorder take black cohosh preparations with caution; the same liver concern applies to people already taking other medicines that can injure the liver (hepatotoxic drugs)
• Tamoxifen and estrogen medicines — some evidence suggests black cohosh may be safely used with tamoxifen in breast cancer survivors, although the EMA breast-cancer warning above still applies; the monograph also states that black cohosh preparations are not used together with estrogen (oestrogen) medicines except on a doctor's advice
• Mild side effects — gastrointestinal upset, headache, and rash occur in a small percentage of users

Back to Table of Contents

Key Research Papers

The following PubMed search links provide curated entry points into the published clinical and mechanistic literature on Black Cohosh (Actaea racemosa). Each link opens directly in PubMed at the National Library of Medicine.

1. Black cohosh for menopausal hot flashes — PubMed: black cohosh menopause hot flashes
2. Cimicifuga racemosa randomized controlled trials — PubMed: Cimicifuga racemosa randomized
3. Black cohosh and serotonin receptors — PubMed: black cohosh serotonin
4. Black cohosh hepatotoxicity safety review — PubMed: black cohosh hepatotoxicity
5. Black cohosh and breast cancer survivors — PubMed: black cohosh breast cancer
6. Triterpene glycosides actein and cimiracemoside — PubMed: actein cimiracemoside
7. Black cohosh quality control and adulteration — PubMed: black cohosh adulteration identification

External Authoritative Resources

1. NCCIH — Herbs at a Glance
2. MedlinePlus — Herbs and Supplements
3. PubMed — All research on Actaea racemosa

Back to Table of Contents

Conditions Black Cohosh Is Used For

Each condition below links to its page. The coloured half of every capsule shows how much human evidence supports this herb for that specific use — traditional use is history, not proof, and is marked as such.

• Women's Health

Connections

• All Herbs
• Menopause: Why the Hormones Fall and What Changes — interactive animation
• Black Cohosh Benefits Deep Dive
• Maca
• Ashwagandha
• Chamomile
• Lemon Balm
• Hormone Panel
• Stress Management
• Perimenopause
• Perimenopause Symptom Tracker
• Polycystic Ovary Syndrome
• Anxiety
• Depression
• Fatigue
• Liver Disease
• Cancer
• Non
• Hot Flashes & Night Sweats
• St Johns Wort
• Dong Quai (Angelica sinensis) — the Chinese blood tonic — a different species from European angelica
• White Peony Root (Bai Shao) — source of Total Glucosides of Paeony, an approved rheumatoid-arthritis drug in China

Back to Table of Contents

Featured Videos

×